Journals / KONURALP TIP DERGİSİ / 2026 / Volume: 18 Issue: 3

Five-Year Clinical Outcomes and Factors Associated With Major Adverse Cardiovascular Events in Transient ST-Segment Elevation Myocardial Infarction: A Retrospective Cohort Study

Direnç Yılmaz(Sakarya University, Training and Research Hospital, Department of Cardiology)0000-0003-1611-4507
Ahmet Can Çakmak(Sakarya University Training and Research Hospital, Department of Cardiology)0000-0001-5168-8907
Pages
—
Publication Date
2026-10-27
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Age, hypertension, and hyperlipidemia were associated with five-year MACE in univariable analyses and may help identify patients at higher long-term cardiovascular risk.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: This study aimed to evaluate five-year clinical outcomes and investigate baseline factors associated with major adverse cardiovascular events (MACE) in patients presenting with transient ST-segment elevation myocardial infarction (STEMI).
📊
Key Findings & Data:Material and Methods: This retrospective, single-center, observational study included 52 patients who presented between January 2019 and December 2020 with ST-segment elevation on the initial electrocardiogram followed by complete resolution before coronary angiography.
💡
Conclusion & Impact:Age, hypertension, and hyperlipidemia were associated with five-year MACE in univariable analyses and may help identify patients at higher long-term cardiovascular risk.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:ST elevation myocardial ınfarction · myocardial reperfusion · major adverse cardiac events

Abstract

Aim: This study aimed to evaluate five-year clinical outcomes and investigate baseline factors associated with major adverse cardiovascular events (MACE) in patients presenting with transient ST-segment elevation myocardial infarction (STEMI). Material and Methods: This retrospective, single-center, observational study included 52 patients who presented between January 2019 and December 2020 with ST-segment elevation on the initial electrocardiogram followed by complete resolution before coronary angiography. The primary outcome was five-year MACE, defined as a composite of cardiovascular death, acute coronary syndrome, revascularization, and ischemic cerebrovascular events. Follow-up data were obtained from hospital records and the national electronic health record system. Patients with and without MACE were compared, and associated factors were examined using univariable logistic regression. Results: The median age was 54.5 years, and 80.8% of patients were male. During five-year follow-up, MACE occurred in 11 patients (21.2%). All-cause mortality was 7.7%, cardiovascular mortality was 1.9%, and acute coronary syndrome and revascularization each occurred in 15.4%. Patients with MACE were older (63.0 vs. 51.0 years; p=0.003) and more frequently had hypertension (72.7% vs. 29.3%; p=0.014) and hyperlipidemia (45.5% vs. 12.2%; p=0.025). In univariable analysis, age (OR: 1.09; 95% CI: 1.02-1.17; p=0.016), hypertension (OR: 6.44; 95% CI: 1.46-28.53; p=0.014), and hyperlipidemia (OR: 6.00; 95% CI: 1.32-27.19; p=0.020) were significantly associated with five-year MACE. Conclusion: Long-term cardiovascular risk was not negligible after transient STEMI despite resolution of ST-segment elevation. Age, hypertension, and hyperlipidemia were associated with five-year MACE in univariable analyses and may help identify patients at higher long-term cardiovascular risk.

🔖

Cite This Article

Yılmaz, D., Çakmak, A. C. (2026). Five-Year Clinical Outcomes and Factors Associated With Major Adverse Cardiovascular Events in Transient ST-Segment Elevation Myocardial Infarction: A Retrospective Cohort Study. KONURALP TIP DERGİSİ, Volume: 18 Issue: 3. https://doi.org/10.18521/ktd.2009362

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (22)

  1. Ferrari R, Balla C, Malagù M, Guardigli G, Morciano G, Bertini M, et al. Reperfusion damage: a story of success, failure, and hope. Circ J. 2017;81(2):131-41. doi:10.1253/circj.CJ-16-1124.
  2. Kumar A, Cannon CP. Acute coronary syndromes: diagnosis and management, part II. Mayo Clin Proc. 2009;84(11):1021-36. doi:10.1016/S0025-6196(11)60674-5.
  3. Janssens GN, van der Hoeven NW, Lemkes JS, Everaars H, van de Ven PM, Marques KMJ, et al. 1-year outcomes of delayed versus immediate intervention in patients with transient ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2019;12(22):2272-82. doi:10.1016/j.jcin.2019.07.018.
  4. Leader JH, Kanji R, Gorog DA. Spontaneous reperfusion in STEMI: its mechanisms and possible modulation. Kardiol Pol. 2024;82(4):363-74. doi:10.33963/v.phj.99737.
  5. Blondheim DS, Kleiner-Shochat M, Asif A, Kazatsker M, Frimerman A, Abu-Fanne R, et al. Characteristics, management, and outcome of transient ST-elevation versus persistent ST-elevation and non-ST-elevation myocardial infarction. Am J Cardiol. 2018;121(12):1449-55. doi:10.1016/j.amjcard.2018.02.029.
  6. Hackett D, Davies G, Chierchia S, Maseri A. Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy. N Engl J Med. 1987;317(17):1055-9. doi:10.1056/NEJM198710223171704.
  7. Meisel SR, Dagan Y, Blondheim DS, Dacca S, Shochat M, Kazatsker M, et al. Transient ST-elevation myocardial infarction: clinical course with intense medical therapy and early invasive approach, and comparison with persistent ST-elevation myocardial infarction. Am Heart J. 2008;155(5):848-54. doi:10.1016/j.ahj.2007.12.010.
  8. Lemkes JS, Janssens GN, van der Hoeven NW, van de Ven PM, Marques KMJ, Nap A, et al. Timing of revascularization in patients with transient ST-segment elevation myocardial infarction: a randomized clinical trial. Eur Heart J. 2019;40(3):283-91. doi:10.1093/eurheartj/ehy651.
  9. Demirkiran A, van der Hoeven NW, Janssens GN, Lemkes JS, Everaars H, van de Ven PM, et al. Left ventricular function, strain, and infarct characteristics in patients with transient ST-segment elevation myocardial infarction compared to ST-segment and non-ST-segment elevation myocardial infarctions. Eur Heart J Cardiovasc Imaging. 2022;23(6):836-45. doi:10.1093/ehjci/jeab114.
  10. Christian TF, Milavetz JJ, Miller TD, Clements IP, Holmes DR, Gibbons RJ. Prevalence of spontaneous reperfusion and associated myocardial salvage in patients with acute myocardial infarction. Am Heart J. 1998;135(3):421-7. doi:10.1016/S0002-8703(98)70317-5.
  11. Stone GW, Cox D, Garcia E, Brodie BR, Morice MC, Griffin J, et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the Primary Angioplasty in Myocardial Infarction trials. Circulation. 2001;104(6):636-41. doi:10.1161/hc3101.093701.
  12. Guo Z, Yang X. Does pre-angiography total ST-segment resolution reliably predict spontaneous reperfusion of the infarct-related artery in patients with acute myocardial infarction? BMC Cardiovasc Disord. 2019;19(1):264. doi:10.1186/s12872-019-1229-6.
  13. Rimar D, Crystal E, Battler A, Gottlieb S, Freimark D, Hod H, et al. Improved prognosis of patients presenting with clinical markers of spontaneous reperfusion during acute myocardial infarction. Heart. 2002;88(4):352-6. doi:10.1136/heart.88.4.352.
  14. Koc L, Mikolaskova M, Novotny T, Parenica J, Kanovsky J, Ondrus T, et al. Primary percutaneous coronary intervention is appropriate in transient ST-elevation myocardial infarction. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022;166(2):180-6. doi:10.5507/bp.2021.005.
  15. Guagliumi G, Stone GW, Cox DA, Stuckey T, Tcheng JE, Turco M, et al. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Circulation. 2004;110(12):1598-604. doi:10.1161/01.CIR.0000142862.98817.1F.
  16. Ye Z, Xu Y, Tang L, Wu M, Wu B, Zhu T, et al. Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram model. Cardiovasc Diabetol. 2023;22(1):87. doi:10.1186/s12933-023-01820-9.
  17. Ayhan E, Uyarel H, Çiçek G, Ergelen M, Işık T, Eren M. Clinical outcomes of primary angioplasty in ST elevation myocardial infarction patients with antecedent hypertension during hospital stay and follow-up. Clin Exp Hypertens. 2012;34(5):357-62. doi:10.3109/10641963.2011.649934.
  18. Reinstadler SJ, Stiermaier T, Eitel C, Saad M, Metzler B, de Waha S, et al. Antecedent hypertension and myocardial injury in patients with reperfused ST-elevation myocardial infarction. J Cardiovasc Magn Reson. 2016;18(1):80. doi:10.1186/s12968-016-0299-1.
  19. Gao M, Zheng Y, Zhang W, Cheng Y, Wang L, Qin L. Non-high-density lipoprotein cholesterol predicts nonfatal recurrent myocardial infarction in patients with ST segment elevation myocardial infarction. Lipids Health Dis. 2017;16(1):20. doi:10.1186/s12944-017-0418-5.
  20. Liao J, Qiu M, Su X, Qi Z, Xu Y, Liu H, et al. The residual risk of inflammation and remnant cholesterol in acute coronary syndrome patients on statin treatment undergoing percutaneous coronary intervention. Lipids Health Dis. 2024;23(1):172. doi:10.1186/s12944-024-02156-3.
  21. Braga CG, Cid-Alvarez AB, Diéguez AR, Alvarez BA, Otero DL, Sánchez RO, et al. Prognostic impact of residual SYNTAX score in patients with ST-elevation myocardial infarction and multivessel disease: analysis of an 8-year all-comers registry. Int J Cardiol. 2017;243:21-6. doi:10.1016/j.ijcard.2017.04.054.
  22. Li Y, Li X, Zhang Y, Zhang L, Wu Q, Bai Z, et al. Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. BMC Cardiovasc Disord. 2020;20(1):36. doi:10.1186/s12872-020-01339-x.